Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
NCT02857517 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2016-08-11
Summary
The purpose of this study is to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as primary treatment for ICNV.
Conditions
- Idiopathic Choroidal Neovascularization
Interventions
- DRUG
-
conbercept
0.05ml conbercept
Sponsors & Collaborators
-
Jiao Mingfei
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2018-06-30
Countries
- China
Study Locations
More Related Trials
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
NCT02175940 ·Status: COMPLETED
-
Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF
NCT02876198 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Biomarkers and Choroidal Neovascularization
NCT04439708 ·Status: ACTIVE_NOT_RECRUITING
-
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NCT02033018 ·Status: UNKNOWN ·Phase: PHASE4
-
Minocycline to Treat Branch Retinal Vein Occlusion
NCT01468831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
NCT03793400 ·Status: COMPLETED
-
Treatment of Corneal Neovascularization With Topical Pazopanib
NCT01257750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy
NCT00347698 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
NCT00407719 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
NCT03680326 ·Status: COMPLETED
-
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
NCT01581411 ·Status: COMPLETED ·Phase: PHASE1
-
Initial Versus Delayed PDT Combination With Conbercept in PCV
NCT02821520 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intravitreal Bevacizumab on Corneal Endothelium
NCT01726790 ·Status: UNKNOWN
-
The Treatment Burden of Myopic Choroidal Neovascularization
NCT07009574 ·Status: NOT_YET_RECRUITING
-
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
NCT00370786 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
NCT02860858 ·Status: COMPLETED ·Phase: PHASE4
-
Bevacizumab for the Treatment of Corneal Neovascularization
NCT00992849 ·Status: UNKNOWN ·Phase: PHASE2
-
Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
NCT01920984 ·Status: COMPLETED ·Phase: NA
-
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
NCT00943072 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
NCT00599820 ·Status: TERMINATED ·Phase: PHASE3